CHMP Give Positive Opinion for New Tecentriq-Based Combination Therapy as an Initial Treatment for Advanced Lung Cancer
Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit